Asunto(s)
Angioedema/diagnóstico , Países en Desarrollo , Dermatosis Facial/diagnóstico , Lepra Multibacilar/diagnóstico , Sinusitis/diagnóstico , Adolescente , Angioedema/tratamiento farmacológico , Angioedema/patología , Biopsia , Enfermedad Crónica , Clofazimina/uso terapéutico , Dapsona/uso terapéutico , Diagnóstico Diferencial , Quimioterapia Combinada , Dermatosis Facial/tratamiento farmacológico , Dermatosis Facial/patología , Estudios de Seguimiento , Humanos , India , Lepra Multibacilar/tratamiento farmacológico , Lepra Multibacilar/patología , Masculino , Rifampin/uso terapéutico , Sinusitis/tratamiento farmacológico , Sinusitis/patología , Piel/patologíaAsunto(s)
Fármacos Dermatológicos/administración & dosificación , Dermatosis Facial/patología , Isotretinoína/administración & dosificación , Enfermedades de las Glándulas Sebáceas/tratamiento farmacológico , Enfermedades de las Glándulas Sebáceas/patología , Administración Oral , Adulto , Biopsia con Aguja , Dermatosis Facial/tratamiento farmacológico , Femenino , Estudios de Seguimiento , Humanos , Hiperplasia/tratamiento farmacológico , Hiperplasia/patología , Inmunohistoquímica , Resultado del TratamientoRESUMEN
Leprosy is an easily recognizable disease due to its dermato-neurological manifestations. It must be present in the physician's diagnostic repertoire, especially for those working in endemic areas. However, leprosy reaction is not always easily recognized by non-dermatologists, becoming one of the major problems in the management of patients with leprosy, as it presents clinical complications characterized by inflammatory process, accompanied by pain, malaise and sometimes the establishment or worsening of the patient's disabilities. We report the case of a patient with type-1 periorbital reaction admitted to the hospital, diagnosed and treated as facial cellulitis, whose late diagnosis may have contributed to the appearance or worsening of facial neuritis.
Asunto(s)
Celulitis (Flemón)/diagnóstico , Dermatosis Facial/diagnóstico , Lepra Dimorfa/diagnóstico , Anciano , Biopsia , Diagnóstico Diferencial , Diagnóstico Precoz , Cara , Dermatosis Facial/tratamiento farmacológico , Humanos , Lepra Dimorfa/tratamiento farmacológico , Masculino , Factores de Tiempo , Resultado del TratamientoRESUMEN
Leprosy is aneasily recognizable disease due to its dermato-neurological manifestations. It must be present in the physician’s diagnostic repertoire, especially for those working in endemic areas. However, leprosy reaction is not always easily recognized by non-dermatologists, becoming one of the major problems in the management of patients with leprosy, as it presents clinical complications characterized by inflammatory process, accompanied by pain, malaise and sometimes the establishment or worsening of the patient’s disabilities. We report the case of a patient with type-1 periorbital reaction admitted to the hospital, diagnosed and treated as facial cellulitis, whose late diagnosis may have contributed to the appearance or worsening of facial neuritis.
.Asunto(s)
Anciano , Humanos , Masculino , Celulitis (Flemón)/diagnóstico , Dermatosis Facial/diagnóstico , Lepra Dimorfa/diagnóstico , Biopsia , Diagnóstico Diferencial , Diagnóstico Precoz , Cara , Dermatosis Facial/tratamiento farmacológico , Lepra Dimorfa/tratamiento farmacológico , Factores de Tiempo , Resultado del TratamientoAsunto(s)
Carcinoma Verrugoso/diagnóstico , Dermatosis Facial/diagnóstico , Leishmaniasis Cutánea/diagnóstico , Neoplasias Cutáneas/diagnóstico , Administración Cutánea , Anciano de 80 o más Años , Antiinfecciosos Locales/administración & dosificación , Antifúngicos/administración & dosificación , Diagnóstico Diferencial , Dermatosis Facial/tratamiento farmacológico , Femenino , Humanos , Cetoconazol/administración & dosificación , Leishmaniasis Cutánea/tratamiento farmacológico , Labio , Nariz , Povidona Yodada/administración & dosificaciónRESUMEN
Red face syndrome is characterized by an erythematous dermatitis that is produced by different entities. These include rosacea, seborrheic dermatitis, contact dermatitis, atopic dermatitis, psoriasis, cutaneous lupus, photodermatosis, post-topical steroid dermatosis, demodicosis, borderline borderline (BB) leprosy, mastocytosis, carcinoid, postneoplasia flushing, cutaneous lymphoma, tineas, ulerythema ophryogenes, and psychosomatic flushing. Red face is a relatively common dermatologic manifestation. Our goal is to review tinea corporis and other fungi that affect this region causing facial erythema and its therapeutic management.
Asunto(s)
Dermatomicosis/diagnóstico , Eritema/microbiología , Dermatosis Facial/diagnóstico , Hongos/aislamiento & purificación , Antifúngicos/uso terapéutico , Dermatomicosis/tratamiento farmacológico , Dermatomicosis/epidemiología , Eritema/epidemiología , Eritema/fisiopatología , Dermatosis Facial/tratamiento farmacológico , Dermatosis Facial/epidemiología , Femenino , Humanos , Masculino , Pronóstico , Medición de Riesgo , Rosácea/tratamiento farmacológico , Rosácea/epidemiología , Rosácea/microbiología , Índice de Severidad de la Enfermedad , Resultado del TratamientoAsunto(s)
Dermatosis Facial/diagnóstico , Leishmaniasis Cutánea/diagnóstico , Antiprotozoarios/uso terapéutico , Dermatosis Facial/tratamiento farmacológico , Dermatosis Facial/parasitología , Humanos , Leishmaniasis Cutánea/tratamiento farmacológico , Masculino , Meglumina/uso terapéutico , Antimoniato de Meglumina , Persona de Mediana Edad , Nariz , Compuestos Organometálicos/uso terapéuticoAsunto(s)
Enfermedades del Ano/etiología , Dermatosis Facial/etiología , Histiocitosis de Células de Langerhans/diagnóstico , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Enfermedades del Ano/patología , Dermatosis Facial/diagnóstico , Dermatosis Facial/tratamiento farmacológico , Hepatomegalia/diagnóstico por imagen , Hepatomegalia/etiología , Histiocitosis de Células de Langerhans/complicaciones , Histiocitosis de Células de Langerhans/tratamiento farmacológico , Humanos , Enfermedades Pulmonares/complicaciones , Enfermedades Pulmonares/diagnóstico por imagen , Masculino , RadiografíaAsunto(s)
Dermatosis Facial/tratamiento farmacológico , Dermatosis Facial/patología , Rosácea/tratamiento farmacológico , Rosácea/patología , Adulto , Antibacterianos/administración & dosificación , Antiinfecciosos/administración & dosificación , Antiinflamatorios no Esteroideos/administración & dosificación , Doxiciclina/administración & dosificación , Femenino , Humanos , Metronidazol/administración & dosificaciónAsunto(s)
Dermatosis Facial/tratamiento farmacológico , Dermatosis Facial/microbiología , Lepra Multibacilar/tratamiento farmacológico , Adulto , Alopecia/complicaciones , Clofazimina/uso terapéutico , Dapsona/uso terapéutico , Cejas , Dermatosis Facial/complicaciones , Humanos , Leprostáticos/uso terapéutico , Lepra Multibacilar/complicaciones , Lepra Multibacilar/diagnóstico , Masculino , Rifampin/uso terapéuticoRESUMEN
BACKGROUND: Organ transplant recipients (OTR) are at high risk of developing cutaneous neoplasms. Topical photodynamic therapy (PDT) has been used for the treatment of actinic keratosis (AK) in OTR. AIMS: The objective was to evaluate the efficacy of PDT with methylaminolevulinate (MAL) in the treatment of facial AK in OTR. As a secondary objective, we wanted to evaluate the usefulness of topical PDT in the reduction of photodamage in OTR. METHODS: A prospective, single center, single arm study was made. 16 OTR were included. Topical PDT was applied for 1 or 2 cycles depending on the patient's characteristics. An evaluation of AK was made at visits pre-treatment, at 12 weeks and at 24 weeks. Photodamage was measured with multispectral image technique (SkinCare). RESULTS: A complete response rate of 100% was achieved for AK in all patients; it persisted without change at 12 and 24 weeks of follow-up. 62.5% of patients improved their photodamage as measured by SkinCare®, but this result was not statistically significant (P = 0.12). All patients had high level of satisfaction at the end of the therapy. CONCLUSIONS: MAL-PDT is an effective therapy for the treatment of AK in OTRs. It can reduce photodamage in this group of patients, but these results were not statistically significant.
Asunto(s)
Ácido Aminolevulínico/análogos & derivados , Queratosis Actínica/tratamiento farmacológico , Fotoquimioterapia , Fármacos Fotosensibilizantes/uso terapéutico , Lesiones Precancerosas/tratamiento farmacológico , Envejecimiento de la Piel/efectos de los fármacos , Adulto , Anciano , Ácido Aminolevulínico/farmacología , Ácido Aminolevulínico/uso terapéutico , Carcinoma de Células Escamosas/inducido químicamente , Carcinoma de Células Escamosas/prevención & control , Dermatosis Facial/tratamiento farmacológico , Dermatosis Facial/patología , Femenino , Humanos , Terapia de Inmunosupresión/efectos adversos , Inmunosupresores/efectos adversos , Queratosis Actínica/patología , Masculino , Persona de Mediana Edad , Trasplante de Órganos/efectos adversos , Satisfacción del Paciente , Fármacos Fotosensibilizantes/farmacología , Dermatosis del Cuero Cabelludo/tratamiento farmacológico , Dermatosis del Cuero Cabelludo/patología , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/prevención & control , Resultado del Tratamiento , Adulto JovenRESUMEN
Familial atrophia maculosa varioliformis cutis is a very rare disorder with less than 28 cases being reported in the literature worldwide and remains a mystery both as far as genetics and the virtue of its pathogenesis is concerned. We present a case of mother and son, both having this disorder with presentations unique in terms of sites involved and try to draw a five generations pedigree chart for the same. We further support its inheritance pattern as autosomal dominant. Also, we propose oral isotretinoin as an effective treatment modality for the same.
Asunto(s)
Dermatosis Facial/genética , Dermatosis Facial/patología , Enfermedades Cutáneas Genéticas/genética , Enfermedades Cutáneas Genéticas/patología , Adolescente , Adulto , Fármacos Dermatológicos/uso terapéutico , Epidermis/patología , Dermatosis Facial/tratamiento farmacológico , Salud de la Familia , Femenino , Genes Dominantes , Humanos , India , Isotretinoína/uso terapéutico , Masculino , Linaje , Enfermedades Cutáneas Genéticas/tratamiento farmacológicoAsunto(s)
Dermatosis Facial/patología , Lepra Dimorfa/patología , Lepra Tuberculoide/patología , Adulto , Antígenos CD/inmunología , Antígenos de Diferenciación Mielomonocítica/inmunología , Linfocitos B/inmunología , Complejo CD3/inmunología , Clofazimina/uso terapéutico , Dapsona/uso terapéutico , Quimioterapia Combinada , Urgencias Médicas , Cara/inervación , Cara/patología , Dermatosis Facial/tratamiento farmacológico , Dermatosis Facial/inmunología , Humanos , Leprostáticos/uso terapéutico , Lepra Dimorfa/tratamiento farmacológico , Lepra Dimorfa/inmunología , Lepra Tuberculoide/tratamiento farmacológico , Lepra Tuberculoide/inmunología , Masculino , Prednisona/uso terapéutico , Receptores de Superficie Celular/inmunología , Rifampin/uso terapéutico , Linfocitos T/inmunología , Resultado del TratamientoRESUMEN
Childhood granulomatous periorificial dermatitis (CGPD) is a self-limiting and well-recognized entity. A six-year-old male child, a known case of juvenile rheumatoid arthritis (JRA) presented with multiple red raised and yellowish lesions over the face, neck, trunk and upper extremities since one month with occasional itching. Cutaneous examination revealed multiple erythematous scaly papules of size up to 5 mm around the mouth, nose and periorbital areas, neck, trunk and upper extremities with few excoriations. Lesional skin biopsy was pathognomic of CGPD. We report a six-year-old Indian male child with extra-facial involvement and healing with small atrophic pigmented scars in a known case of JRA.
Asunto(s)
Dermatosis Facial/diagnóstico , Granuloma/diagnóstico , Combinación Amoxicilina-Clavulanato de Potasio/uso terapéutico , Antibacterianos/uso terapéutico , Niño , Clorfeniramina/uso terapéutico , Diagnóstico Diferencial , Dermatosis Facial/tratamiento farmacológico , Dermatosis Facial/patología , Granuloma/tratamiento farmacológico , Granuloma/patología , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Humanos , Masculino , Cuello , Torso , Extremidad SuperiorRESUMEN
A 45-year-old male presented with a 6 month history of an enlarging smooth, erythematous plaque over the central part of his face. Mild erythema of both eyes was present. Sarcoidosis, Hansen disease, lupus vulgaris, cutaneous leishmaniasis, pseudolymphoma, foreign body granuloma, granuloma faciale, discoid lupus erythematosus, and granulomatous rosacea were considered in the differential diagnosis. CBC, urinalysis, renal function tests, liver function tests, serum electrolytes, and blood sugar were all normal. Chest X-ray and ECG revealed no abnormality. Serology for syphilis and HIV, and mantoux test were negative. Slit-skin smear, tissue smear and culture for AFB and fungi were negative. Skin biopsy revealed multiple non-caseating epitheloid granulomas around the pilosebaceous unit suggestive of granulomatous rosacea. Granulomatous rosacea, a rare entity comprising only about 10 percent of cases of rosacea can mimic many granulomatous conditions both clinically and histologically making the diagnosis an enigma. It usually presents as yellowish brown-red discrete papules on the face; non-caseating epithelioid granulomas are seen on histology examination. We herein report the case because it presented in atypical fashion, as a solitary indurated plaque on the nose, likely representing Morbihan's disease or solid persistent facial edema of rosacea (rosacea lymphedema).